WallachBeth Capital announced the completion of an underwritten public offering of 1,510,455 units of Bone Biologics (NASDAQ: BBLG) at an offering price of $5.25 per unit for total gross proceeds of $7.9 million, before deducting underwriting discounts and commissions and other estimated offering expenses. Bone Biologics’ common stock and warrants began trading on the Nasdaq Capital Market on October 13, 2021, under the symbols “BBLG” and “BBLGW” respectively.